Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality7/10

Herbalife reaffirms 2026 outlook, signaling continued YoY net sales growth

Aug 31, 2026, 9:57 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Reaffirmed guidance reduces execution risk and provides clearer near-term upside potential if macro conditions remain favorable; history shows guidance updates can shift multiples modestly when accompanied by stable FX and apparent momentum.

AI summary

What happened, with direct paths to the underlying reporting

Herbalife reaffirmed its guidance for Q3 2026 and the full year, maintaining expected YoY net sales growth in both reported and constant currency terms and holding its adjusted EBITDA target. The unchanged FX assumptions and steady momentum across its distributor network reinforce the growth trajectory into 2026. This reiteration should limit near-term downside and may support upside if macro conditions improve.

Herbalife reaffirms Q3 and FY2026 guidance.
Q3’25 actuals: net sales 1,273.7m; margin 12.8%.
Full-year CC net sales growth: +2.5% to +5.5% YoY; EBITDA unchanged.
FX assumptions unchanged from Aug 5, 2026 guidance.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Herbalife reaffirms 2026 outlook, signaling continued YoY net sales growth

Cristiano Ronaldo Invests $7.5 Million Into Herbalife—Stock Surges